Faeth Therapeutics, Inc FTH

US Biotechnology

$27.24 ▼ -5.48% ($-1.58)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $29.51

Prev Close $28.82

Day Range $26.26 – $30.10

52W Range $13.43 – $37.90

Market Cap $702.21M

Beta 1.25

EPS (TTM) $-142.73

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-02-04
Shares Out.	25,780,000
Website	senseibio.com ↗
Phone	18008998648
Employees	29

About Faeth Therapeutics, Inc

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Faeth Therapeutics, Inc is a publicly traded company under the ticker symbol FTH on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.